ArticleEuropean journal of neurology2015

Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.

N Voloshyna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.